Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07586917 · ClinicalTrials.gov registry record · NA
Optimizing Pregnancy and Treatment Interventions for Moms 3.0
A NA study, sponsored by University of Utah.
- Not yet
- Registry status
- NA
- Development phase
- 429
- Enrollment target
NCT07586917: Clinical Trial NA study, sponsored by University of Utah.
NCT07586917 is a NA study that has not yet begun recruiting, run by University of Utah. The registered enrollment target is 429 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07586917, a NA study, has not yet begun recruiting, sponsored by University of Utah.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 429 participants
- Enrollment target
Study Summary
We want to learn if Patient Navigation helps pregnant Medicaid members with opioid use disorder, with or without stimulant use disorder, stay in care, use medications for opioid use disorder, reduce substance use, and connect with services, compared to usual care. Enrolled participants will be randomly assigned (by chance, like flipping a coin) to one of two groups: Usual Care or Patient Navigation. Participate will last up to 14 months and participants randomized to Patient Navigation may have about 14 sessions/calls with a Patient Navigator (30-45 minutes each) and complete 3 surveys (30-60 minutes each). All visits can be by phone or video.
Primary Outcome
14-panel urine toxicology Timeline Follow Back (TLFB)
Interventions
- BEHAVIORAL Patient Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 429 participants |
| Start Date | 2026-06 |
| Est. Completion | 2030-06 |
| Phase | NA |
What is known before NCT07586917 opens enrollment
NCT07586917 is an interventional study that assigns participants to a tested intervention. The registered 429 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.
NCT07586917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07586917 about?
NCT07586917 is a clinical study titled "Optimizing Pregnancy and Treatment Interventions for Moms 3.0". We want to learn if Patient Navigation helps pregnant Medicaid members with opioid use disorder, with or without stimulant use disorder, stay in care, use medications for opioid use disorder, reduce substance use, and connect with services, compared to usual care. Enrolled participants will be rand...
What is the current status of trial NCT07586917?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 429 participants. The study started on 2026-06. Estimated completion is 2030-06.
What interventions are being tested in trial NCT07586917?
The interventions under investigation include: Patient Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT07586917?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07586917's enrollment target sits among peer trials
429 236th of 2000 higher than 1,765 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05932862 · 429 participants · Phase 1
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05532982 · 430 participants
Parkinson's Disease in Asian Americans
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia